Linden Advisors’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-250,000
Closed -$429K 807
2021
Q4
$429K Buy
+250,000
New +$425K ﹤0.01% 566

Other funds holding HLGN.WS

Linden Advisors's HLGN.WS Position: Q1 2022 in Review

Linden Advisors sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q1 2022, closing a stake of 250,000 shares — an estimated $429K sold.

Linden Advisors first reported a position in HLGN.WS in Q4 2021 and held it in 1 quarter. The position peaked at $429K in Q4 2021. 17 funds tracked by Wall St. Rank hold HLGN.WS as of Q1 2022.

  • Linden Advisors reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q1 2022 after selling out during the quarter.
  • Linden Advisors sold 250,000 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q1 2022, an estimated $429K.
  • Linden Advisors first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2021 and held it in 1 quarter.
  • Linden Advisors's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $429K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q1 2022.

Based on Linden Advisors's 13F filing for Q1 2022, filed 16 May 2022.